Congenital genu recurvatum

disease
On this page

Also known as genu recurvatumhyperextension deformity of kneehyperextension of knee deformity

Summary

Congenital genu recurvatum (MONDO:0017560) is a disease and 3 clinical trials. A subtype of congenital knee dislocation — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namecongenital genu recurvatum
Mondo IDMONDO:0017560
Orphanet295229
ICD-111709221347
NCITC103184
SNOMED CT205063003
UMLSC0152235
MedGen508941
GARD0021225
Is cancer (heuristic)no

Also known as: genu recurvatum · hyperextension deformity of knee · hyperextension of knee deformity

Disease family

This is a subtype of congenital knee dislocation. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by developmental or physiological process › disorder of development or morphogenesiscongenital knee dislocationcongenital genu recurvatum

Related subtypes (1): congenital genu flexum

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified3

Top trials by phase / activity

NCTPhaseStatusTitle
NCT06647082Not specifiedNOT_YET_RECRUITINGEngaging Kids With Robotic Exoskeletons and Gamification
NCT07008521Not specifiedACTIVE_NOT_RECRUITINGUNIVERSAL EXERCISE UNIT and REBOUND THERAPY ON GENU RECURVATUM Cerebral Palsy Childeren
NCT02854189Not specifiedCOMPLETEDThe Results of Oxford Unicompartmental Knee Arthroplasty in Patients With and Without Preoperative Genu Recurvatum

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.